Abstract
Several parameters calculated with a new functional imaging agent for the liver, Tc-99m DTPA-galactosyl human serum albumin, were evaluated in 9 patients with liver cirrhosis, one with hepatocellular carcinoma, and five with both liver cirrhosis and hepatocellular carcinoma. LU3, which represents the cumulative uptake of the tracer from 3 to 4 minutes after injection, showed a strong correlation (r=0.858, p=0.0001) with LHL15, which represents the count ratio for the liver to sum for the liver and heart 15 minutes-after injection of the tracer. It also showed a strong correlation (r= −0.896, p=0.0001) with the indocyanine green retention rate (ICGR15). Regional ICGR15 is therefore calculable from the regional LU3. GSAR15, which represents the radioactivity of the tracer retained in the blood 15 minutes after injection, showed a strong correlation (r=0.878, p=0.0001) with HH15, which represents the count ratio for the heart 15 minutes after injection of the tracer divided by the count for the heart 3 minutes after injection. In conclusion, LU3 and GSAR15 are interesting and promising parameters for assessing liver function.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Sawamura T, Nakada H, Hazama H, et al: Hyperasialoglycoproteinemia in patients with chronic liver diseases and/or liver cell carcinoma.Gestroenterology 87: 1217–1221, 1984
Sawamura T, Kawasato S, Tsuda M, et al: Clinical application of the measurement of serum asialoglycoproteins to estimate residual liver function in patients with chronic liver diseases with or without hepatocellular carcinoma.Gastroenterol Jpn 20: 201–208, 1985
Hazama H, Kawa S, Kubota Y, et al: A new liver functional test using the asialoglycoprotein-receptor system on the liver cell membrane: III. Evaluation for usefulness by liver function test using the Tc-99m-neoglycoprotein (Jpn).Kaku Igaku 23: 917–926, 1986
Kudo M, Toda A, Ikekubo K, et al: Estimation of hepatic functional reserve by asialoglycoprotein receptor-binding radiolabeled synthetic ligand “Tc-99m-galactosyl-neoglycoalbumin”: Preclinical and clinical studies (Jpn).Kaku Igaku 24: 1653–1662, 1987
Stadalnik RC, Vera DR, Woodle ES, et al: Technetium-99m NGA functional hepatic imaging: Preliminary clinical experience.J Nucl Med 26: 1233–1242, 1985
Vera DR, Krohn KA, Stadalnik RC, et al: Tc-99m galactosylneoglycoalbumin: In vivo characterization of receptor-mediated binding.J Nucl Med 25: 779–787, 1984
Bossuyt A, DeGeeter F, Jacobs A, et al: Initial clinical experience with a new kit formation of Tc-99m-β galactosylated albumin for functional hepatic imaging.Nucl Med Comm 11: 469–475, 1990
Vera DR, Stadalnik RC, Trudeau WL, et al: Measurement of receptor concentration and forward-binding rate constant via radiopharmacokinetic modeling of technetium-99m-galactosyl-neoglycoalbumin.J Nucl Med 32: 1169–1176, 1991
Kudo M, Vera DR, Trudeau WL, et al: Validation ofin vivo receptor measurements viain vitro radioassay: Technetium-99m-galactosyl-neoglycoalbumin as prototype model.J Nucl Med 32: 1177–1182, 1991
Torizuka K, Ha-Kawa SK, Kudo M, et al: Phase II clinical study on Tc-99m GSA, a new agent for functional imaging of the liver (Jpn).Kaku Igaku 29: 85–95, 1992
Ha-Kawa SK, Kojima M, Suga Y, et al: Dose estimation of Tc-99m-DTPA-galactosyl-human serum albumin (Tc-99m-GSA) in the blood with nonlinear regression method (Jpn).Kaku Igaku 28: 425–428, 1991
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Koizumi, K., Uchiyama, G., Arai, T. et al. A new liver functional study using Tc-99m DTPA-galactosyl human serum albumin: Evaluation of the validity of several functional parameters. Ann Nucl Med 6, 83–87 (1992). https://doi.org/10.1007/BF03164647
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03164647